April 24 (UPI) --The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract infections, the U.S. Food and Drug Administration announced ...

Share on Pinterest The Food and Drug Administration approved Pivya to treat uncomplicated urinary tract infections in female adults. Maskot/Getty Images Experts describe UTIs as “uncomplicated” when ...

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and adolescent girls. The drug is made by British pharmaceutical company GSK.

SEATTLE — For the first time in 20 years, the Food and Drug Administration (FDA) approved a new antibiotic to treat urinary tract infections in the U.S., easing concerns of antibiotic resistance. A ...

Vaginal probiotics reduce the incidence of recurring urinary tract infections (UTIs). The finding suggests the treatment is a promising alternative to antibiotics, many of which are no longer ...

There is a significant unmet medical need for an effective, non-antibiotic prophylactic intervention for recurrent urinary tract infections. The sublingual vaccine provides an effective treatment ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

Pivmecillinam has been used for decades in Europe and may work for UTIs that don’t respond to other antibiotics. Urinary tract infections are one of the most common reasons for antibiotic use.